Viewing data from:

PENICILLIN V POTASSIUM

ANDA

PENICILLIN V POTASSIUM | A060518 | IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA

3 strengths0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Penicillin V Potassium (2023)

Total Spending

$3.7M

Total Claims

503,480

Beneficiaries

384,413

Avg Cost/Unit

$0.21

Spending Trend

$5.2M(2019)→$4.3M(2020)→$4.2M(2021)→$4.1M(2022)→$3.7M(2023)

YoY Change:-7.7%

5yr CAGR:-3.5%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

API Supply Chain2 active DMFs10 inactive

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

SANDOZ GMBHPENICILLIN V POTASSIUM

DMF 132951998

BIOTIKA ASPENICILLIN V POTASSIUM

DMF 139631999

TEVA PHARMACEUTICALS USA INCInactivePENICILLIN V POTASSIUM

DMF 132131998

SQUIBBInactivePENICILLIN V POTASSIUM

DMF 132871998

LILLY RESEARCH LABORATORIESInactivePENICILLIN V POTASSIUM

DMF 133321998

BRISTOL MYERS SQUIBB COInactivePENICILLIN V POTASSIUM

DMF 133461998

GIST-BROCADES NV PHARMACEUTICALSInactivePENICILLIN V POTASSIUM

DMF 133551998

PFIZER INCInactivePENICILLIN V POTASSIUM

DMF 133751998

DISTA PRODUCTS CO DIV ELI LILLY AND COInactivePENICILLIN V POTASSIUM

DMF 134171998

PFIZER INCInactivePENICILLIN V POTASSIUM

DMF 134241998

FERMENTA PRODUCTS INCInactivePENICILLIN V POTASSIUM

DMF 135041998

GIST-BROCADES NV PHARMACEUTICALSInactivePENICILLIN V POTASSIUM

DMF 135551998

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — EQ 125MG BASE

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.

#002 — EQ 250MG BASE

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Approved Prior to Jan 1, 1982

#003 — EQ 500MG BASE

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Approved Prior to Jan 1, 1982